Skip to content
Product
Pipeline
OLPRUVA™ Investigational Lifecycle Opportunities
EDSIVO™ for vEDS
Patients & Physicians
Patient Advocacy
Publications
Maple Syrup Urine Disease (MSUD)
Vascular Ehlers-Danlos Syndrome (vEDS)
Expanded Access
Contact Us
About
Pipeline
Investor Relations
Publications
Contact Us
Investor FAQs
Analyst Coverage
Corporate Governance
Stock Information
Events & Presentations
About
Pipeline
Investor Relations
Publications
Contact Us
0001564590-21-014487
SEC Reports
QUICK
NAV
MENU
MENU
About
Acer Management
Board of Directors
Key Strategic Consultants
Scientific Advisory Board
Product
Pipeline
Careers
OLPRUVA™ Investigational Lifecycle Opportunities
EDSIVO™ for vEDS
Patients & Physicians
Patient Advocacy
Publications
Maple Syrup Urine Disease (MSUD)
Vascular Ehlers-Danlos Syndrome (vEDS)
Expanded Access
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Analyst Coverage
Stock Information
Corporate Governance
Investor FAQs
Contact Us
